Focused Wealth Management, Inc - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 147 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.43 and the average weighting 0.0%.

Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$768
+28.0%
8000.0%0.00%
Q1 2023$600
+103.4%
8000.0%0.00%
Q4 2022$2958000.0%0.00%
Q3 2022$0
-100.0%
8000.0%0.00%
Q2 2022$1,0000.0%8000.0%0.00%
Q1 2022$1,0000.0%8000.0%0.00%
Q4 2021$1,000
-50.0%
8000.0%0.00%
Q3 2021$2,000
-33.3%
8000.0%0.00%
Q2 2021$3,000
-80.0%
800
-80.0%
0.00%
-100.0%
Q4 2019$15,000
-54.5%
4,0000.0%0.00%
-55.6%
Q3 2019$33,000
-2.9%
4,0000.0%0.01%0.0%
Q2 2019$34,000
-20.9%
4,0000.0%0.01%
-30.8%
Q1 2019$43,000
+22.9%
4,0000.0%0.01%
+8.3%
Q4 2018$35,000
-47.8%
4,0000.0%0.01%
-47.8%
Q3 2018$67,000
-20.2%
4,0000.0%0.02%
-20.7%
Q2 2018$84,000
+31.2%
4,0000.0%0.03%
+45.0%
Q1 2018$64,000
-15.8%
4,0000.0%0.02%
-16.7%
Q4 2017$76,000
+35.7%
4,0000.0%0.02%
+26.3%
Q3 2017$56,000
+86.7%
4,0000.0%0.02%
+72.7%
Q2 2017$30,000
+15.4%
4,0000.0%0.01%
+10.0%
Q1 2017$26,000
+44.4%
4,0000.0%0.01%
+25.0%
Q4 2016$18,000
-5.3%
4,0000.0%0.01%0.0%
Q3 2016$19,000
-26.9%
4,0000.0%0.01%
-33.3%
Q2 2016$26,000
+8.3%
4,0000.0%0.01%
-14.3%
Q4 2015$24,0000.0%4,0000.0%0.01%
-6.7%
Q1 2015$24,0004,0000.02%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,177,115$1,495,0001.27%
ARMISTICE CAPITAL, LLC 9,665,756$12,276,0000.20%
CM Management, LLC 150,000$191,0000.14%
FSB PREMIER WEALTH MANAGEMENT, INC. 200,000$254,0000.11%
Manteio Capital LLC 57,586$73,0000.09%
GSA CAPITAL PARTNERS LLP 410,691$522,0000.07%
SYNTAX ADVISORS, LLC 29,181$37,0000.03%
CAXTON ASSOCIATES LP 164,096$208,0000.02%
Alpine Global Management, LLC 97,650$124,0000.02%
Sonora Investment Management Group, LLC 82,000$104,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders